RxDoctor Payments Data

R Williams

Cardiovascular Disease · Durham, NCNPI 1982753901

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,000,182 of the $2,141,887 with a category attached, or 93.4%. Amgen accounts for 68.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $538,359 and has fallen 98.4% since, to $8,691 in 2025. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,141,887in general payments, 2019–2025

Across 392 payments — averaging $5464.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1.5M
  • Bristol Myers Squibb$496K
  • E.r. Squibb & Sons, L.L.C.$183K

What the payments were for

  • Consulting fees$8,5990%
  • Speaking & faculty fees$2,000,18293%
  • Travel & lodging$88,4974%
  • Food & beverage$44,6092%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen385$1,463,450
Bristol Myers Squibb5$495,543
E.r. Squibb & Sons, L.L.C.2$182,895

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,141,887 in reported general payments places this provider in the 95th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina →

Other cardiovascular disease in Durham

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →